epclusa
gilead sciences ireland uc - sofosbuvir, velpatasvir - epatite c, cronica - antivirali per uso sistemico - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 e 5.
blincyto
amgen europe b.v. - blinatumomab - linfoma di leucemia linfoblastica a cellule precursori - agenti antineoplastici - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.
epclusa compresse rivestite con film
gilead sciences switzerland sàrl - sofosbuvirum, velpatasvirum - compresse rivestite con film - sofosbuvirum 400 mg, velpatasvirum 100 mg, copovidonum, cellulosum microcristallinum, carmellosum natricum solo tenuti insieme, magnesio stearas, Überzug: poli(alcole vinylicus), macrogolum 3350, talco, e 171, e 172 (rosso), per compresso haze corrisp. sodio 2.85 mg. - chronische epatite c - synthetika
lincospectin
zoetis italia s.r.l. - lincomicina cloridrato, spectinomicina solfato - lincomicina cloridrato - 56.7 milligrammo (i); spectinomicina solfato - nd, lincomicina cloridrato - 222 milligrammo (i); spectinomicina solfato - 444.7 milligrammo (i), spectinomicina solfato - 444.7 mg; lincomicina cloridrato - 222 mg, lincomicina cloridrato - 56.7 mg; spectinomicina solfato - nd, lincomicina cloridrato - 222 mg; spectinomicina solfato - 444.7 mg, spectinomicina solfato - nd ; lincomicina cloridrato - 56.7 mg - lincomycin, combinations
usa series ureteroscope
gyrus acmi inc - strumentazione per endoscopia uro-genitale non altrimenti classificata
usa series ureteroscope
gyrus acmi inc - strumentazione per endoscopia uro-genitale non altrimenti classificata
usa series ureteroscope
gyrus acmi inc - strumentazione per endoscopia uro-genitale non altrimenti classificata
usa series ureteroscope
gyrus acmi inc - strumentazione per endoscopia uro-genitale non altrimenti classificata
usa cysto-telescope adapter
gyrus acmi inc - strumentazione per acquisizione e gestione di immagini endoscopiche e di chirurgia mini-invasiva - componenti accessori hardware
usa elite system cystourethroscope short bridge, examining
gyrus acmi inc - strumentazione per acquisizione e gestione di immagini endoscopiche e di chirurgia mini-invasiva - componenti accessori hardware